Immunohistochemical analysis of malignancy grade in patients with intrahepatic cholangiocarcinoma.

Immunohistochemical analysis of malignancy grade in patients with intrahepatic cholangiocarcinoma. - Immunohistochemical analysis of malignancy grade in patients with intrahepatic cholangiocarcinoma.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009210

Enrollment

100

Registered

2012-11-01

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic cholangiocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Surgical cases with the diagnosis of intrahepatic cholangiocarcinoma

Exclusion criteria

Exclusion criteria: Below the age of 20.

Design outcomes

Primary

Measure	Time frame
Expression frequency of EGFR,VEGF,HER2,Ki-67,CK8,CK18,CK7,CK19 etc.	—

Secondary

Measure	Time frame
Prognosis	—

Countries

Japan

Contacts

Public ContactRyusei Matsuyama

Yokohama City University Graduated school of Medicine Department of Gastroenterological Surgery

045-787-2650

Outcome results